BPC157+TB500 / 10 Vial

What is BPC-157?

BPC-157 is a synthetic pentadecapeptide (15 amino acids; MW ≈ 1,419.5 Da) derived through academic research from a protein sequence originally identified in gastric juice. It has been the subject of preclinical research in laboratory settings since the 1990s. It is intended strictly for laboratory and research purposes.

Molecular & Structural Profile

BPC-157 is a stable 15-amino-acid peptide notable in peptide chemistry literature for its resistance to hydrolysis in gastric environments — an unusual characteristic among small peptides. Its molecular stability profile and lack of sequence homology to other known peptides have made it a subject of ongoing structural pharmacology research.

Areas of Active Scientific Investigation

Cellular Pathway Research: Investigations into nitric oxide (NO) signaling and growth factor receptor pathways in cellular models.

Structural Pharmacology: Studies examining peptide stability and hydrolysis resistance under varying pH conditions.

Comparative Peptide Research: Studies examining BPC-157 alongside other gastric-derived peptides in receptor assays.

Molecular Biology Studies: Academic research into gene expression pathways in in vitro models.

Regulatory & Research Context

BPC-157 is sold strictly for in vitro research and laboratory use only. It is not intended for human or veterinary use, consumption, or application of any kind. It is not approved by the FDA to diagnose, treat, cure, or prevent any disease or condition. Not for use in any living organism.

Scientific References

• Sikiric P, et al. Current Pharmaceutical Design. 2010.
• Seiwerth S, et al. Current Pharmaceutical Design. 2014.
• PubMed: PMC8388779 | PMC9966208